Clinical Trials and Other Neurology Research
The listing below features the research initiatives under way at the St. Luke's Center for Neuroscience.
As part of the Huntington Study Group (HSG), Dr. Nancy Diaz is serving as an investigator in the 2 Care study, a multi-center, randomized, double-blind, placebo-controlled study of coenzyme Q10 (CoQ) in individuals with Huntington's Disease (HD) to assess the effects of CoQ on the progression of functional decline in HD, as well as the long-term safety and tolerability. Over six hundred research participants are in enrolled at clinical sites in the US, Canada, and Australia.
Study is underway. Enrollment is now closed.